Jubilant Life Sciences has issued Commercial Papers (CPs) of Rs 100 crore. The tenure of the instrument is 63 days and allotted on April 18, 2017. The coupon/interest will be paid upfront at the rate of 6.49% per annum on maturity i.e. June 20, 2017. With this issue, the aggregate amount of commercial papers outstanding as on date is Rs 100 crore.
Jubilant Life Sciences is an integrated global Pharmaceutical and Life Sciences Company engaged in manufacture and supply of APIs, Solid Dosage Formulations, Radiopharmaceuticals, Allergy Therapy Products and Life Science Ingredients.
